Includes the prevention and treatment of venous and arterial thromboembolism.
Myocardial infarction, ischemic stroke, mesenteric thrombosis and peripheral artery disease are the consequences of arterial thrombosis (depending on the site of the occlusion). Pulmonary embolism is a consequence of the dettachment of a venous thrombosis.
The accurate detection, prevention and medical treatment of patients at risk are the aims of Vascular Medicine.
THROMBOEMBOLIC DISEASE
Mean age of patients with pulmonary embolism is 70 years, with similar proportion of men and women.
In Spain there were 22,250 patients with pulmonary embollism during 2010. Of these, 8.9% died during admission.Deep vein thrombosis and pulmonary embolism are two manifestations of the same disease: venous thromboembolism.

Deep vein thrombosis appears when the blood is clotting inside a vein. It usually occurs in the lower limbs, and it may produce pain, swelling and increased temperature in the calf. But sometimes it is absolutely silent.

As the blood inside a vein runs to the heart, and from the heart to the lungs, when a clot dettaches the vein wall it will go until the pulmonary arteries. Once in the lungs, it occludes one or more arteries: this is a pulmonary embolism.
ПРОЦЕДУРЫ
  • ANTICOAGULATION IN DVT: LOW MOLECULAR WEIGHT HEPARIN
  • NEW ORAL ANTICOAGULANTS
Thrombophilia means a number of abnormalities (congenital or acquired)
associated with a higher risk for thrombosis.Women who are pregnant or taking hormonal therapy have a high risk for thrombosis if they have thrombophilia.
Factor V Leiden and prothrombin mutation are the two congenital thrombophilic defects more common. They may be detected with a simple blood test.
ПРОЦЕДУРЫ
  • ANTICOAGULATION IN DVT: LOW MOLECULAR WEIGHT HEPARIN
  • NEW ORAL ANTICOAGULANTS